Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Apr;28(4):958-61.
doi: 10.1038/leu.2014.8. Epub 2014 Jan 10.

Myelodysplastic/myeloproliferative neoplasms, unclassifiable (MDS/MPN, U): natural history and clinical outcome by treatment strategy

C D DiNardo  1 , N Daver  1 , N Jain  1 , N Pemmaraju  1 , C Bueso-Ramos  2 , C C Yin  2 , S Pierce  1 , E Jabbour  1 , J E Cortes  1 , H M Kantarjian  1 , G Garcia-Manero  1 , S Verstovsek  1
Affiliations

Myelodysplastic/myeloproliferative neoplasms, unclassifiable (MDS/MPN, U): natural history and clinical outcome by treatment strategy

C D DiNardo et al. Leukemia. 2014 Apr.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Overall Survival by (a) MF-IPSS, (b) MDS-IPSS, (c) IPSS-R and (d) MDA global model classification systems
See this image and copyright information in PMC

References

    1. Swerdlow SHCE, Harris LH, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th Edition ed. International Agency for Research on Cancer (IARC); Lyon: 2008.
    1. Orazi A, Germing U. The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, UK. 2008 Jul;22(7):1308–19. PubMed PMID: 18480833. Epub 2008/05/16. eng. - PubMed
    1. Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009 Jul 30;114(5):937–51. PubMed PMID: 19357394. Epub 2009/04/10. eng. - PubMed
    1. Wang SA, Hasserjian RP, Loew JM, Sechman EV, Jones D, Hao S, et al. Refractory anemia with ringed sideroblasts associated with marked thrombocytosis harbors JAK2 mutation and shows overlapping myeloproliferative and myelodysplastic features. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, UK. 2006 Sep;20(9):1641–4. PubMed PMID: 16871284. Epub 2006/07/28. eng. - PubMed
    1. Atallah E, Nussenzveig R, Yin CC, Bueso-Ramos C, Tam C, Manshouri T, et al. Prognostic interaction between thrombocytosis and JAK2 V617F mutation in the WHO subcategories of myelodysplastic/myeloproliferative disease-unclassifiable and refractory anemia with ringed sideroblasts and marked thrombocytosis. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, UK. 2008 Jun;22(6):1295–8. PubMed PMID: 18059483. Epub 2007/12/07. eng. - PubMed

MeSH terms